Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly

Neuroendocrinology Letters

Volumn 30, Issue 2, 2009, Pages 245-255

  Jaskula, Magdalena ^a,b   Wasko, Ryszard ^a   Komarowska, Hanna ^a   Dziubandowska, Aleksandra ^a   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Department of Endocrinology Metabolism and Internal Medicine   (Poland)

Author keywords

Acromegaly; Acylated ghrelin; Cholesterol; Pituitary tumors; Total ghrelin; Triglycerides

Indexed keywords

CHOLESTEROL; GHRELIN; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OCTREOTIDE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ACROMEGALY; ACYLATION; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE;

EID: 70349321188     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S. (2006). A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliterator-Activated Receptor γ-Dependent Pathway. Mol Endocrinol 20(12): 3165-3178.
2. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA. (2003). Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab; 88: 2180-2184.
3. Beaumont N, Skinner V, Tan TM, Ramesh BS, Byrne D, Mac Coll GS et al. (2003). Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 278(11): 8877-8880. (Pubitemid 36800362)
4. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M. (2001). Ghrelin, a natura GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab; 86(10): 5083-5086. (Pubitemid 33020569)
5. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M. (2004). Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in human. J Clin Endocrinol Metab 2004; 89: 3062-3065. (Pubitemid 38766409)
6. Broglio F, Koetsveld PP, Benso A, Gottero C, Prodam F, Papotti M. (2002). Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 87: 4829-4832. (Pubitemid 35247084)
7. Cappiello V, Ronchi C, Morpurgo PS, Espaminonda P, Arosio M, Beck-Peccoz P. (2002). Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol; 47: 189-194. (Pubitemid 34928615)
8. Casanueva FF, Dieguez C. (2005). Leptin and ghrelin: what is the impact on pituitary function? Rev Endocr Metab Disord; 6: 39-45.
9. Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC. (2006). Polymorphisms in the Ghrelin Gene Are Associated with Serum High-Density Lipoprotein Cholesterol Level and not with Type 2 Diabetes Mellitus in Koreans. J Clin Endocrinol Metab 91(11): 4657-4663.
10. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG. (2004) The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors. Eur J Endocrinol; 150: 715-718. (Pubitemid 38786543)
11. Colao A, Ferone D, Marzullo P, Lombardi G. (2004). Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. Endocr Rev; 25(1): 102-152. (Pubitemid 38269977)
12. Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L. (2003). Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab; 88(7): 3117-3120. (Pubitemid 36877481)
13. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisie BE, Weigle DS. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes; 50: 1714-1719. (Pubitemid 33641587)
14. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al. (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med; 346: 1623-1630. (Pubitemid 34755670)
15. De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C. (2007). Ghrelin interacts with human plasma lipoproteins. Endocrinol 148(5): 2355-2362. (Pubitemid 46997038)
16. Demers A, McNicoll N, Febbraio M, Servant M, Marleau S, Silverstein R. (2004). Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J; 382: 417-424.
17. Dimaraki EV, Jaffe CA. (2006). Role of endogenous ghrelin in growth secretion, appetite regulation and metabolism. Rev Endocr Metab Disord; 7(4): 237-249
18. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV. (2003). The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab. 284: E313-E316.
19. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL (2003). Serum ghrelin levels in acromegaly: effects of surgical and longacting octreotide therapy. J Clin Endocrinol Metab 2003; 88: 2037-2044.
20. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G. (2005). Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol; 62: 1-17. (Pubitemid 40175277)
21. Gmiński J, Kopeć J. (2003). Mate geste LDL - wyzwanie terapeutyczne dla statyn. Przewodnik Lekarza 6, 7/8: 36-42.
22. Horvath TL, Diano S, Sotonyi P, Heiman ML, Tschop M. (2002). Ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology, 142(10): 4163-4169.
23. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M. et al. (2004). Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chemistry 50: 1077-1080. (Pubitemid 38725803)
24. Jarkovska Z, Rosicka M, Marek J, Hana V, Weiss V, Justova V. (2006). Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Physiol Res; 55: 175-181.
25. Kawamata T, Inui A, Hosoda H, Kengawa K., Hori T. (2007). Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalisation of serum GH. Clin Endocrinol 67: 140-144. (Pubitemid 46955454)
26. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature; 402: 656-660. (Pubitemid 129516334)
27. Kojima M, Hosoda H, Matsuo H, Kangawa K. (2001). Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends in Endocrinol Metab; 12: 118-122. (Pubitemid 33714199)
28. Kojima M, Kangawa K. (2005). Ghrelin: structure and function. Physiol Rev; 85: 495-522.
29. Kozakowski J, Rabijewski M, Zgliczynski W. (2005). Decrease in serum ghrelin levels in patients with acromegaly normalize after successful surgical treatment. Endokrynol Pol; 56(6): 862-870
30. Leite-Moreira AF, Soares J-B. (2007). Physiological, pathological and potential therapeutic role of ghrelin. Drug Discovery Today; 12(7/8): 276-288. (Pubitemid 46467484)
31. Miraglia del Giudice E, Santoro N, Cirillo G, Raimondo P, Grandone A, D'Aniello A. (2004). Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord 28: 447-450.
32. Mucioli G. et al. (2004). Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498: 27-35.
33. Muller AF, Lamberts SWJ, Janssen JA, Hofland LJ, Van Koetsveld P, Bidlingmaier M. et al (2002). Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol; 146: 203-207. (Pubitemid 34162912)
34. Nagaya N, Uematsu M, Kojima M, Date Y, Yamagishi M, Oya H et al. (2001). Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationship between ghrelin and anabolic/catabolic factors. Circulation; 104: 2034-2038.
35. Norrelund H, Hansen TK, Orskov H, Hosoda H, Kojima M, Kangawa K. (2002). Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf); 57: 539-546.
36. Otto B. et al. (2004) Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol 151: 113-117. (Pubitemid 39117372)
37. Pagotto U., Gambineri A, Pelusi C, Cacciari M, Otto B, Castaneda T, Tschop M et al. (2003). Testesteron replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 88: 4139-4143. (Pubitemid 37153711)
38. Poykko S, Ukkola O, Kauma H, Savolainen MJ, Kesaniemi YA (2003a). Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia; 46: 455-458. (Pubitemid 36577786)
39. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. (2003b). Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes. Diabetes; 52: 2546-2553. (Pubitemid 37210544)
40. Poykko SM, Kellokoski E, Ukkola O, Kauma H, Paivansalo M, Kesaniemi YA. (2006). Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Inter Med; 260(1): 43-52.
41. Purnell JQ, Weigle D, Breen P, Cummings D. (2003). Ghrelin levels correlate with insulin levels, insulin resistance ad high-density lipoprotein cholesterol, but not with gender, menopausal status or cortisol levels in humans. J Clin Endocrinol Metab 88(12): 5747-5750. (Pubitemid 38033045)
42. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. (2002). Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87: 3997-4000. (Pubitemid 34879561)
43. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M. (2002). Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87: 240-244. (Pubitemid 34084697)
44. Sun Y, Ahmed S, Smith RG. (2003). Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol; 23(22): 7973-7981. (Pubitemid 37377491)
45. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson I. (2004). Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinol 145(1): 234-242.
46. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. (2001). Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest; 146: 203-207.
47. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. (2001). Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709. (Pubitemid 32242624)
48. Tsolakis AV, Portela-Gomes M, Stridsberg M, Grimelius L, Sundin A, Eriksson B et al.(2004) Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab; 89(8): 3739-3744.
49. Van der Lely A, Tschop M, Heiman ML, Ghigo E. (2004). Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin. Endor Rev; 25(3): 426-457. (Pubitemid 38780667)
50. Van der Toorn F, Janssen J, de Herder W, Broglio F, Ghigo E, Van der Lely A. (2002). Central ghrelin production doeas not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly. Eur J Endocrinol; 147: 195-199. (Pubitemid 34928616)